-
2981
Pediatric Sickle Cell Disease in Sudan: Complications and Management
Published 2022-01-01“…Prophylactic penicillin was prescribed for 15% of patients, and 41.1% were immunized with pneumococcal vaccine (PPSV23). Most patients had been scheduled for planned follow-up visits every 3–6 months (93.2%). …”
Get full text
Article -
2982
The type of infections and the use of antibiotics among patients with rheumatoid arthritis: A review
Published 2025-01-01“…Additionally, it is important to administer vaccinations for specific pathogens (such as pneumococcal, herpes zoster, and influenza) before and during treatment. …”
Get full text
Article -
2983
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Published 2025-01-01“…Multiple forms of cancer immunotherapy, including immune checkpoint inhibitors (ICIs), adoptive cell therapy and cancer vaccines, have become widely available. However, the effectiveness of these immunotherapies is not much satisfying. …”
Get full text
Article -
2984
-
2985
Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes
Published 2022-04-01“…Severe acute respiratory syndrome CoV (SARS-CoV), Middle East respiratory syndrome CoV (MERS-CoV), and the novel coronavirus (2019-nCoV, SARS-CoV-2) have been identif ied as causing global pandemics. Clinically tested vaccines are widely used to control rapidly spreading, acute, and often severe infections; however, effective drugs are still not available. …”
Get full text
Article -
2986
STUDY ON THE ESTIMATION OF SARS-CoV-2 VIRUS PATHOGENS’ TRANSMISSION PROBABILITIES FOR DIFFERENT PUBLIC BUS TRANSPORT SERVICE SCENARIOS
Published 2023-09-01“…The study draws on scenarios from the first and second waves of the COVID-19 pandemic in Poland, a period that was devastatingly marked by the lack of available vaccines. This study aims to add value to the scientific community by offering an estimation of the likelihood of SARS-CoV-2 transmission in public transport and a preliminary risk assessment for COVID-19 infection, considering the number of active, non-isolated COVID-19 cases in the Polish population. …”
Get full text
Article -
2987
An Overview on The Pandemic Coronavirus Disease 2019 (COVID-19) Outbreak
Published 2020-05-01“…At the moment nothing can stop the virus from spreading, neither vaccine nor medicines were found to stop the virus and secure life of people of the planet. …”
Get full text
Article -
2988
-
2989
-
2990
Twitter (X) and the Commercial Determinants of Health: Characterizing the Most Amplified, Influential, and Connected Voices Driving Twitter Discourse About Tobacco Regulatory Polic...
Published 2025-01-01“…We sampled the 100 most followed, amplified (retweets), influential (H index), and connected (betweenness centrality) users at three different time periods: pre-COVID (September 2019 to February 2020), COVID lockdown (March 2020 to March 2021), and post vaccine rollout (April to July 2021) to characterize top users. …”
Get full text
Article -
2991
RETRACTED ARTICLE: Clinical and immuno-proteomic approach on Lantana camara pollen allergy—a major health hazard
Published 2016-07-01“…The allergens identified thereof can be used to prepare hypoallergenic vaccine candidates and design immunotherapy trials against LC pollen and other aeroallergen carriers which are cross-reactive and harbor similar proteins.…”
Get full text
Article -
2992
Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial.
Published 2025-01-01“…Widespread use of the measles vaccine has decreased measles antibody potency in the United States plasma supply. …”
Get full text
Article -
2993
The schistosome oesophageal gland: initiator of blood processing.
Published 2013-01-01“…The binding of host antibodies in the esophageal lumen shows that some constituents are antibody targets and could provide a new source of vaccine candidates.…”
Get full text
Article -
2994
Drivers of success in global health outcomes: A content analysis of Exemplar studies.
Published 2024-01-01“…The EGH studies (N = 31) spanned six topics including under-five child mortality (n = 6), childhood stunting (n = 5), community health workers (CHW) (n = 4), vaccine delivery (n = 3), COVID-19 response (n = 6), and newborn and maternal mortality reduction (n = 7) across 19 countries in sub-Saharan Africa, Latin America, South and Central Asia, and the Caribbean regions. …”
Get full text
Article -
2995
The problem of norovirus infection in animals (literature review)
Published 2024-06-01“…The investigations of the etiology of numerous diarrhea cases revealed rota-, corona-, parvo-, enteroviruses and bovine viral diarrhea virus in fecal samples from calves. Inactivated vaccines have been developed in the Russian Federation to prevent viral diarrhea in cattle. …”
Get full text
Article -
2996
Etio-clinical profile and coronary angiographic characteristics of rural patients with acute inferior wall myocardial infarction
Published 2024-12-01“…The mean systolic blood pressure and diastolic blood pressure were 127.23 ± 30.71 mmHg and 77.98 ± 15.83 mmHg, respectively. 4 (3.9%) had COVID-19 disease and 102 (99%) were vaccinated for it. The total occlusion of the vessel was found among 71 (68.9%) subjects. …”
Get full text
Article -
2997
Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus
Published 2024-12-01“…Abstract Hepatitis C virus (HCV) presents a significant global health issue due to its widespread prevalence and the absence of a reliable vaccine for prevention. While significant progress has been achieved in therapeutic interventions since the disease was first identified, its resurgence underscores the need for innovative strategies to combat it. …”
Get full text
Article -
2998
Current Status, Challenges, Policies, and Bioethics of Biobanks
Published 2013-12-01Get full text
Article -
2999
Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine
Published 2018-01-01“…A follow-up schedule and administration of booster dose of HBV vaccine is strongly recommended for β-thalassemia patients whose anti-HBs level <10 IU/ml.…”
Get full text
Article -
3000